IN THE HIGH COURT FOR THE STATE OF TELANGANA AT HYDERABAD
K. SUJANA, J.
Vijay Kumar Kanoria – Petitioner
Versus
The State of Telangana – Respondent
Criminal Petition No. 147 of 2024
Decided On : 02-09-2024
(A) Code of Criminal Procedure, 1973 – Section 482 – Drugs and Cosmetics Act, 1940 – Section 18(a)(vi) – Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 – Quashing of proceedings against former director of accused company – The petitioner was not a director at the time of the complaint registration, and thus cannot be held liable for the company's actions. (Paras 5, 12, 15)
(B) Vicarious Liability – The court reiterated that mere directorship does not impose liability unless the individual was in charge of the company's conduct at the time of the offence. (Paras 6, 10)
(C) Limitation – The complaint was filed beyond the limitation period as per Section 469 of Cr.P.C., constituting an abuse of process. (Paras 7, 8)
Facts of the case :
The petitioner, a former director of M/s. Gena Pharmaceuticals, sought to quash proceedings initiated against him for alleged violations of drug regulations, asserting he was not in charge at the time of the alleged offence.
Findings of Court :
The court found that the petitioner was not liable as he was not a director when the complaint was filed, and the proceedings were quashed.
Issues : Whether the petitioner can be held liable for the company's actions post his directorship and the applicability of limitation on the complaint.
Ratio Decidendi : The court held that liability requires active involvement in the company's conduct at the time of the offence, and the complaint was time-barred.
Result : Criminal petition allowed, quashing the proceedings.
ORDER :
1. This Criminal Petition is filed under Section 482 of Code of Criminal Procedure, 1973 (for short ‘Cr.P.C.’) seeking to quash the order dated 07.12.2023 passed in PRC No. 52 of 2022 on the file of the I Additional Junior Civil Judge cum I Additional Judicial Magistrate of First Class, at Miryalaguda.
2. The brief facts of the case are that the petitioner is the former Director of accused company, namely, M/s. Gena Pharmaceuticals Limited. The respondent/de facto complainant filed PRC No. 52 of 2022 alleging contraventions of Section 18(a) (vi) read with Rule 106 and Schedule J point No. 50 of the Drugs and Cosmetics Act, 1940 (for short ‘Act, 1940’) and Drugs and Cosmetics Rules, 1945 (for short ‘Rules 1945’) and also violation under Section 3(d) read with Schedule point 22 (Kidney Stones) of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 (for short ‘Act 1954’) against accused company-M/s. Gena Pharmaceuticals.
3. As per the complaint averments, on 18.05.2015 on receipt of credible information, LWs. 3 and 4 went to the premises of M/s. Divya Medical and General Stores and on inspection of the said premises, they found stocks of 2 x 200 ML of potrate MB6 oral solution bearing details, such as, batch No. IT 1503, manufacturing date January 2015, expiry date June 2016 and manufactured by M/s. Gena Pharmaceuticals Limited, Door No. 7/2/1, Thakurpukur Road, Kolkata, West Bengal, marketed by M/s. Intas Pharmaceuticals Limited, Matoda, Ahmedabad, Gujarat-382210. It was alleged that the indication on the label of the drug as potrate MB6 for management of calcium oxalate nephrolithiasis (especially in hyper oxaluria cases and uric acid neptrolithiasis) violates Section 18(a) (vi) read with Rule 106, read with Schedule J point No. 50 of Act, 1940 and Rules 1945 and also Section 3(d) read with point 22 (kidney stones) of Act, 1954 (objectionable advertisements), thereby, the respondent/de facto complaint seized the drugs by listing them in Form-16 in the presence of witnesses under a cover of panchanama. For the offences as alleged, PRC, proceedings were initiated against the petitioner/accused stating that the accused company is represented by petitioner. Aggrieved thereby, this Criminal Petition is filed.
4. Heard Sri Zubin J.F. Poovathinkal, learned counsel for petitioner and Sri D. Arun Kumar, learned Additional Public Prosecutor, appearing for respondent.
5. Learned counsel for petitioner, submitted that the petitioner is neither accused in the complaint, nor the authorized representative of the accused company. He contended that on 09.08.2019 the National Company Law Tribunal, Kolkata, admitted application bearing No. CP(IB) No. 731/KB/2022 filed by the financial creditor under Section 7 of the Insolvency and Bankruptcy Code, 2016 for initiating CIRP against the accused company and vide CIRP commencement order, an Interim Resolution Professional (for short ‘IRP’) assumed charge and was in full control of the accused company. Consequently, the CIRP process was unsuccessful and the accused company is under liquation till date. He asserted that as per the company data of accused company on the website of Ministry of Corporate Affairs (MCA) (www.mca.gon.in) the petitioner was the Director of the company till 30.09.2019 whereas, PRC No. 52 of 2022 was registered before the trial Court on 24.11.2022 and on that date, the petitioner was not the Director of the accused company and the company was under complete control of liquidator, as such, the petitioner is incapacitated to represent the accused company in the PRC proceedings.
6. In addition, learned counsel for petitioner incessantly contended that no individual criminal liability was imposed on petitioner in the complaint lodged by the Drugs Inspector. He reiterated that the only person against whom the complaint was made is against the accused company. In support of the said contention, he relied on the judgment rendered by the Hon’ble Supreme Court in State of
Cheminova India Limited and Others vs. State of Punjab and Others
Chunduru Siva Ram Krishna vs. Peddi Ravindra Babu
Devendra vs. State of Uttar Pradesh
Inder Goswami vs. State of Uttaranchal
Ravindranatha Bajpe vs. Mangalore Special Economic Zone Limited and Others
A former director cannot be held liable for a company's actions if they were not in charge at the time of the alleged offence, and complaints filed beyond the limitation period constitute an abuse of....
Vicarious liability under Section 34 of Drugs and Cosmetics Act requires specific complaint averments that director/MD in charge and responsible for company business conduct; mere designation insuffi....
Liability under the Drugs and Cosmetics Act requires clear averments in the complaint regarding the accused's managerial responsibility; mere directorship is insufficient without evidence of control ....
Directors liable under Drugs Act Section 34 if complaint specifically avers their involvement in business conduct via emails and records, notwithstanding competent person appointment.
Specific averments showing a Director's responsibility for the company's conduct of business are necessary to establish vicarious liability under the Essential Commodities Act, 1955.
Proper arraying of the accused in a complaint is essential for prosecution under the Drugs and Cosmetics Act, 1940.
Vicarious liability under the Drugs and Cosmetic Act arises only if the person was in charge and responsible for the company's conduct of business at the material time.
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.